Author

F. A. Schultz

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

A. J. Luna· 1 shared D. F. Kusewitt· 1 shared H. Kang· 1 shared J. M. Young· 1 shared M. A. Ozbun· 1 shared R. T. Sterk· 1 shared V. Bondu· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. J. Luna

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Inhibition of Cellular MEK/ERK Signaling Suppresses Murine Papillomavirus Type 1 Replicative Activities and Promotes Tumor Regression

A. J. Luna, J. M. Young, R. T. Sterk, V. Bondu, F. A. Schultz, D. F. Kusewitt, H. Kang, M. A. Ozbun

This paper shows that MEK1/2 inhibitors reduce MmuPV1 replication and promote tumor regression in mice, suggesting MEK1/2 as a therapeutic target for papillomavirus diseases.

bioRxiv · Mar 14, 2023Cancer Biology